Abstract
We investigated the clinical characteristics, management modalities, and outcomes in patients with relapsing polychondritis (RP) with airway involvement. The medical records of RP patients with airway involvement seen at Samsung Medical Center from August 2004 to December 2011 were collected. The clinical manifestations were investigated retrospectively, including rheumatologic record, diagnostic tests, treatment modalities, and clinical outcomes. Twelve patients (five females, seven males) with a median age of 48(interquartile range (IQR) 44–60) years were included. All patients had airway involvement, including the trachea (100 %), main bronchi (83 %), and larynx (25 %). Rheumatological manifestations were frequent, including inflammatory arthritis (50 %), auricular chondritis (42 %), keratoconjunctivitis (42 %), nasal chondritis (42 %), saddle nose (25 %), and sensorineural hearing loss (17 %). All patients who had acute exacerbations were treated with high-dose corticosteroids (1,000 mg per day) and were maintained on oral prednisolone (5–40 mg per day), with weekly methotrexate (2.5–15 mg per week) during follow up. One out of 12 patients required mechanical ventilation. Nine patients have survived without ventilator support and eight patients without a tracheostomy. Two patients underwent a tracheostomy with endobronchial stenting. During follow-up (median 24[IQR 7–50] months), the clinical outcome was favorable in nine patients, while three patients died of pneumonia and respiratory failure. High-doses of corticosteroids during an acute exacerbation followed by maintenance prednisolone with methotrexate could be recommended as a therapeutic option in RP patients with airway involvement. Airway intervention by an experienced clinician is sometimes required.
Similar content being viewed by others
References
Lahmer T, Treiber M, von Werder A, Foerger F, Knopf A, Heemann U, Thuermel K (2010) Relapsing polychondritis: an autoimmune disease with many faces. Autoimmun Rev 9:540–546
Pearson CM, Kline HM, Newcomer VD (1960) Relapsing polychondritis. N Engl J Med 263:51–58
McAdam LP, O’Hanlan MA, Bluestone R, Pearson CM (1976) Relapsing polychondritis: prospective study of 23 patients and a review of the literature. Medicine 55:193–215
Eng J, Sabanathan S (1991) Airway complications in relapsing polychondritis. Ann Thorac Surg 51:686–692
Carrion M, Giron JA, Ventura J, Camacho A, Garcia-Diez C (1993) Airway complications in relapsing polychondritis. J Rheumatol 20:1628–1629
Kent PD, Michet CJ Jr, Luthra HS (2004) Relapsing polychondritis. Curr Opin Rheumatol 16:56–61
Gergely P Jr, Poor G (2004) Relapsing polychondritis. Best Pract Res Clin Rheumatol 18:723–738
Damiani JM, Levine HL (1979) Relapsing polychondritis-report of ten cases. Laryngoscope 89:929–946
Letko E, Zafirakis P, Baltatzis S, Voudouri A, Livir-Rallatos C, Foster CS (2002) Relapsing polychondritis: a clinical review. Semin Arthritis Rheum 31:384–395
Ryu YJ, Kim H, Yu CM, Choi JC, Kwon YS, Kim J, Suh SW (2006) Comparison of natural and Dumon airway stents for the management of benign tracheobronchial stenosis. Respirology 11:748–754
Park HY, Kim H, Koh WJ, Suh GY, Chung MP, Kwon OJ (2009) Natural stent in the management of postintubation tracheal stenosis. Respirology 14:583–588
Zeuner M, Straub RH, Rauh G, Albert ED, Scholmerich J, Lang B (1997) Relapsing polychondritis: clinical and immunogenetic analysis of 62 patients. J Rheumatol 24:96–101
Quinsat D, Harle JR, Durand JM, Weiller PJ, Mongin M (1989) Relapsing polychondritis and cancer. two cases. Ann Med Interne 140:422–423
Staats BA, Utz JP, Michet CJ Jr (2002) Relapsing polychondritis. Semin Respir Crit Care Med 23:145–154
Kong KO, Vasoo S, Tay NS, Chng HH (2003) Relapsing polychondritis: an Oriental case series. Singapore Med J 44:197–200
Ernst A, Rafeq S, Boiselle P, Sung A, Reddy C, Michaud G, Majid A, Herth FJ, Trentham D (2009) Relapsing polychondritis and airway involvement. Chest 135:1024–1030
Segel MJ, Godfrey S, Berkman N (2004) Relapsing polychondritis: reversible airway obstruction is not always asthma. Mayo Clin Proc 79:407–409
Lin ZQ, Xu JR, Chen JJ, Hua XL, Zhang KB, Guan YJ (2010) Pulmonary CT findings in relapsing polychondritis. Acta Radiol 51:522–526
Lee KS, Ernst A, Trentham DE, Lunn W, Feller-Kopman DJ, Boiselle PM (2006) Relapsing polychondritis: prevalence of expiratory CT airway abnormalities. Radiology 240:565–573
Sarodia BD, Dasgupta A, Mehta AC (1999) Management of airway manifestations of relapsing polychondritis: case reports and review of literature. Chest 116:1669–1675
Gibson GJ, Davis P (1974) Respiratory complications of relapsing polychondritis. Thorax 29:726–731
Krell WS, Staats BA, Hyatt RE (1986) Pulmonary function in relapsing polychondritis. Am Rev Respir Dis 133:1120–1123
Mohsenifar Z, Tashkin DP, Carson SA, Bellamy PE (1982) Pulmonary function in patients with relapsing polychondritis. Chest 81:711–717
Kemta Lekpa F, Kraus VB, Chevalier X (2012) Biologics in relapsing polychondritis: a literature review. Semin Arthritis Rheum 41:712–719
Karaman E, Duman C, Cansz H, Ylmaz M, Ibrahimov M (2010) Laryngotracheal reconstruction at relapsing polychondritis. J Craniofac Surg 21:211–212
Michet CJ Jr, McKenna CH, Luthra HS, O’Fallon WM (1986) Relapsing polychondritis. Survival and predictive role of early disease manifestations. Ann Intern Med 104:74–78
Masaoka A, Yamakawa Y, Niwa H, Hara F, Kondo S, Fukai I, Kiriyama M (1996) Pediatric and adult tracheobronchomalacia. Eur J Cardiothorac Surg 10:87–92
Disclosures
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hong, G., Kim, H. Clinical characteristics and treatment outcomes of patients with relapsing polychondritis with airway involvement. Clin Rheumatol 32, 1329–1335 (2013). https://doi.org/10.1007/s10067-013-2279-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-013-2279-2